Intelligence · Clinical pipeline
Phase III Pipeline Programs
Late-stage pivotal and registrational clinical programs nearing regulatory submission.
Quick answer
NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.
Top sponsors
- Takeda 393 programs
- United Therapeutics Europe 199 programs
- Anaxis Pharma 198 programs
- Chinese Academy of 189 programs
- Teva Pharma 148 programs
- Novartis India 145 programs
- BRIGHT MINDS BIOSCIENCES 139 programs
- PARItec 139 programs
- HOFFMANN-LA ROCHE 134 programs
- Regeneron UK 129 programs
- AstraZeneca 120 programs
- First People's Hospital 117 programs
Pipeline programs
-
Champix
Hospital Authority, Hong Kong
Tobacco Use Disorder
1 trial -
Chemotherapy
The First People's Hospital of Lianyungang
Acute Lymphoblastic Leukemia
1 trial -
Chemotherapy
Sun Yat-sen University
Nasopharyngeal Carcinoma
1 trial -
Chemotherapy
United Therapeutics Europe Ltd
Transitional Cell Carcinoma of Ureter
1 trial -
Chemotherapy
International Peace Maternity and Child Health Hospital
Non Small Cell Lung Cancer
1 trial -
Chemotherapy
The First People's Hospital of Lianyungang
Endometrial Cancer
1 trial -
Chemotherapy + avelumab followed by avelumab + talazoparib
Pfizer
Ovarian Cancer
1 trial -
Chemotherapy drug
Chinese PLA General Hospital
Gastric Cancer
1 trial -
Chestnut Bloomington Outpatient (CBOP)
BRIGHT MINDS BIOSCIENCES INC.
Substance Abuse
1 trial -
Chickenpox Vaccines
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chickenpox Vaccines
1 trial -
ChimeriVax-JE, Japanese Encephalitis vaccine
Sanofi Pasteur
Encephalitis
1 trial -
Chirhostim
The George Institute
Pancreatic cancer, Intraductal papillary mucinous intraductal neoplasia
1 trial -
Chlorhexidine
United Therapeutics Europe Ltd
Infant, Newborn, Diseases
1 trial -
Cholecalciferol
United Therapeutics Europe Ltd
Chronic Obstructive Pulmonary Disease
1 trial -
Cholecalciferol
United Therapeutics Europe Ltd
Asthma
1 trial -
Cholecalciferol (Vitamin D/Vigantol oil)
United Therapeutics Europe Ltd
Respiratory Tract Infections
1 trial -
Cholic Acid
Mirum Pharmaceuticals International B.V.
Bile Acid Synthesis Defect
1 trial -
Cholic Acids
Mirum Pharmaceuticals International B.V.
Infantile Refsum's Disease
1 trial -
Cholic acid
Mirum Pharmaceuticals International B.V.
Inborn Errors of Bile Acid Synthesis
1 trial -
Choline Chloride for Injection
Protara Therapeutics
Choline Deficiency
1 trial -
Chronocort®
NEUROCRINE BIOSCIENCES INC
Congenital Adrenal Hyperplasia
5 trials -
Cidofovir, Brincidofovir
Lacuna Pharma Pty Ltd
Adenovirus viremia
1 trial -
Cilta-cel
Janssen Cilag International NV
Multiple Myeloma
1 trial -
Cinryze®
Takeda
Acute Antibody-Mediated Rejection (AMR)
1 trial -
Cipaglucosidase Alfa
AMICUS THERAPEUTICS PTY LTD
Pompe Disease (Late-onset)
1 trial -
Ciprofloxacin (BAYQ3939) dry powder for inhalation
Bayer HealthCare AG
Bronchiectasis
1 trial -
Cisplatin
Children's Hospital of Fudan University
Localized Osteosarcoma
1 trial -
Cisplatin
BRIGHT MINDS BIOSCIENCES INC.
Squamous Cell Carcinoma of Head and Neck
1 trial -
Cisplatin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Nasopharyngeal Carcinoma
1 trial -
Cisplatin /ml Concentrate for Advanced head and neck cancer
Ningbo Cancer Hospital
Advanced head and neck cancer
1 trial -
Cladribine (MAVENCLAD®)
United Therapeutics Europe Ltd
Advanced Multiple Sclerosis
1 trial -
Clamp-Crushing technique
The First People's Hospital of Lianyungang
Hepatobiliary Disease
1 trial -
Clascoterone
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Acne Vulgaris
1 trial -
Claseprubart
Dianthus Therapeutics, Inc. /DE/
Chronic Inflammatory Demyelinating Polyneuropathy
1 trial -
Class I or III Antiarrhythmic Medications
Rhythm Pharmaceuticals Netherlands B.V.
Atrial Fibrillation
1 trial -
Clazakizumab
CSL Behring GmbH
Antibody-mediated Rejection
1 trial -
Clemizole HCl
Harmony Biosciences Holdings
Lennox Gastaut Syndrome
1 trial -
Clemizole HCl
Harmony Biosciences Holdings
Dravet Syndrome
1 trial -
Clesrovimab
Merck KGaA, Darmstadt, Germany
Respiratory Syncytial Virus Infection
1 trial -
Clifutinib
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Leukemia, Acute Myeloid (AML)
1 trial -
Clonidine HCL
BRIGHT MINDS BIOSCIENCES INC.
Neonatal Abstinence Syndrome
2 trials -
Clonidine HCl Mucoadhesive Buccal Tablet
Monopar Therapeutics
Chemoradiotherapy-Induced Severe Oral Mucositis
1 trial -
Clopidogrel
Eli Lilly and Company
Acute Coronary Syndrome
1 trial -
Cloxacilin
Lxo Ireland Designated Activity Company
Staphylococcus
1 trial -
Co-Trimoxazole 960Mg Dispersible Tablet
United Therapeutics Europe Ltd
Spontaneous Bacterial Peritonitis
1 trial -
Coagulation Factor VIIa (Recombinant)
Laboratoire HRA Pharma
Hemophilia
1 trial -
Coenzyme Q10 and Lisinopril
United Therapeutics Europe Ltd
Duchenne Muscular Dystrophy
1 trial -
Cognitive Behavioral Therapy
BRIGHT MINDS BIOSCIENCES INC.
Stress Disorders, Post-Traumatic
1 trial
Frequently asked questions
How many Phase III pipeline programs are in the directory?
5,427 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.